Here are updated and valid real questions to pass SEND exam

killexams.com proposes you should endeavor its 100 percent free brain dumps test. You will actually want to download VCE test system and introduce to your PC to rehearse SEND dumps. We offer you three months of free updates of SEND SEND Endocrinology and Diabetes (Specialty Certificate Examination) practice test questions and practice tests. Our group remains refreshing the SEND Exam Braindumps from genuine inquiries constantly.

Exam Code: SEND Practice test 2022 by Killexams.com team
SEND Endocrinology and Diabetes (Specialty Certificate Examination)
MRCPUK Endocrinology approach
Killexams : MRCPUK Endocrinology approach - BingNews https://killexams.com/pass4sure/exam-detail/SEND Search results Killexams : MRCPUK Endocrinology approach - BingNews https://killexams.com/pass4sure/exam-detail/SEND https://killexams.com/exam_list/MRCPUK Killexams : Diabetes & Endocrinology News
  • New Deep Dive Into Paxlovid Interactions With CVD Meds A new review paper tackles potential drug-drug interactions with the antiviral drug and today's most commonly prescribed cardiovascular drugs.

    Medscape Medical News, October 14, 2022

  • Add Cardiac CT to Acute Stroke Imaging to Detect Cardioembolism Including cardiac CT in the initial stroke imaging protocol detects more high-risk cardioaortic embolic sources than the current practice of performing later echo, a new study shows.

    Medscape Medical News, October 14, 2022

  • Could Pot Prevent a Pot Belly? The Skinny on Cannabis A new study shows the obesity rate is slowing in a state where cannabis is legal. Coincidence? Maybe not.

    WebMD Health News, October 13, 2022

  • AAP 2022 Screening Gaps Miss Childhood Heart Problems People with a rare genetic condition may miss out on decades of treatment for lack of screening in childhood, according to researchers.

    Medscape Medical News, October 13, 2022

  • It's About Location: PCOS Symptoms Differ Depending Where You Live Women with PCOS in California, where metabolic dysfunction was more prevalent, were more likely to have hyperandrogenemia compared with those in Alabama, but age and BMI weren't factors, nor was race.

    Medscape Medical News, October 13, 2022

  • AHA Pens Roadmap to More Patient-Focused Care for PAD The AHA calls for individualizing PAD care through patient-reported outcome measures and developing metrics to ensure high-quality care that could be tied to reimbursement.

    Medscape Medical News, October 13, 2022

  • New Generation of Weight Loss Medications Offer Promise People now have at their disposal more medicines that are effective at reducing weight. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.

    Kaiser Health News, October 13, 2022

  • Success for Basilar Artery Stroke Thrombectomy: Trials Published Two randomized trials have shown benefits of endovascular therapy for Chinese patients with moderate to severe basilar artery ischemic strokes, but further trials are warranted in broader populations.

    Medscape Medical News, October 13, 2022

  • Cardiac Biomarkers Track With Hormone Therapy in Transgender People A pilot study spotlights concentration differences in two common biomarkers of cardiac disease as well as the need for greater inclusivity in cardiovascular trials.

    Medscape Medical News, October 13, 2022

  • Intensive Blood Pressure Reduction Benefits Malignant LVH Intensive blood pressure lowering has substantial benefits for both the prevention and treatment of malignant left ventricular hypertrophy, a new analysis of the SPRINT trial shows.

    Medscape Medical News, October 13, 2022

  • Best Practices for an LGBTQ+ Friendly Medical Space Though a growing percentage of the population identifies as LGBTQ+, some community members still feel unseen when they visit a medical space. Here are some best practice ideas for LGBTQ+ friendly care.

    Medscape Medical News, October 13, 2022

  • Dermatologists Embrace Low-Dose Oral Minoxidil for Hair Loss The inexpensive medication is safe and has relatively few drawbacks, say dermatologists.

    Medscape Medical News, October 12, 2022

  • One Type of Older Diabetes Drug Cuts Dementia Risk, Another Ups It Observational study data suggest thiazolidinediones may be protective when it comes to dementia risk in patients with type 2 diabetes, whereas sulfonylureas increase the risk, compared with metformin.

    Medscape Medical News, October 11, 2022

  • Vanderbilt to Review Gender-Affirming Surgeries for Minors "We should not allow permanent, life-altering decisions that hurt children," Lee tweeted late Friday. "With the partnership of the General Assembly, this practice should end in Tennessee."

    Associated Press, October 11, 2022

  • College Admission Scandal Doc May Lose Medical License A California physician embroiled in the 2019 "Operation Varsity Blues" college admissions scandal could see his medical license revoked after serving time in prison.

    Medscape Medical News, October 11, 2022

  • Weight Loss History Affects Success in Obesity Management A retrospective study of patients at a Canadian weight-loss clinic yields a surprising finding about the success of older women with experience in dieting.

    Medscape Medical News, October 11, 2022

  • Melanoma Increases: a UV Exposure or Diagnostic Scrutiny Problem? A new analysis found that proxies of high medical scrutiny correlate with higher melanoma incidence, while proxies of UV radiation exposure show weak or no correlations.

    Medscape Medical News, October 11, 2022

  • Adding Cardiac Shockwave to CABG Boosts LVEF, Function, QoL Direct epicardial cardiac shockwave therapy adjunctive to CABG might lead to a paradigm shift in the treatment of ischemic cardiomyopathy, researchers suggest.

    Medscape Medical News, October 11, 2022

  • Dual Therapy Restores Radioiodine Uptake in Thyroid Cancer Investigators addressed the "holy grail" in thyroid oncology: how to jump-start radioactive iodine when it stops working for patients with thyroid cancer.

    Medscape Medical News, October 11, 2022

  • Bariatric Surgery Prompts Visceral Fat Reduction, Cardiac Changes Weight loss after bariatric surgery was tied to favorable cardiac effects associated with reduction in visceral fat.

    MDedge News, October 10, 2022

  • Wed, 12 Oct 2022 12:00:00 -0500 text/html https://www.medscape.com/index/list_6337_0
    Killexams : Best Hospitals for Diabetes & Endocrinology No result found, try new keyword!Compare hospital ratings for diabetes and endocrinology. U.S. News evaluated 763 hospitals and ranked the top 50 that see many challenging endocrinology patients for adrenal, pituitary and thyroid ... Wed, 05 Oct 2022 02:10:00 -0500 text/html https://health.usnews.com/best-hospitals/rankings/diabetes-and-endocrinology Killexams : European Society of Endocrinology

    Endocrine disrupting chemicals (EDCs) are one of the most pressing health challenges of the 21st century. The European Commission holds annual forums gathering stakeholders to address this issue. Experts connected to the European Society of Endocrinology intervened about the importance of the thyroid pathway for EDCs and the impact of bisphenols as a group on children. 

    The EDC Forum is a yearly gathering of experts from the public and corporate sectors, convened by the directorate general for Environment (DG ENV) of the European Commission. Participants share knowledge and best practices, pinpoint problems, and create synergies.

    Impact on hormone pathways should be considered holistically
    The European Chemicals Agency and Member States have so far considered the properties of each EDC individually in assessments on their potential restriction. Endocrinologists look at endocrine pathways, such as the thyroid or the adrenal gland, for which it is important to look at not just the effect of not just one substance but the mix of substances that may interfere with this pathway. Thyroid disease is one of the most common endocrine diseases, impacting millions of people throughout Europe.2 Andreas Kortenkamp, ESE expert and Professor of Human Molecular Toxicology at Brunel University in London, described the vital research being conducted by Eurion, a research cluster focused on improving the detection of endocrine disruptors in Europe. Professor Kortenkamp explained the importance of thyroid hormones for healthy brain development. He highlighted that inadequate test methods and regulatory approaches fail to protect us from the dangers of chemical exposures to brain development. He explained that clinicians regard thyroid hormone changes as adverse, while current EU EDC criteria fail to recognise the adversity of such changes. He said: “The EDC criteria should be changed to classify thyroid hormone changes as adverse. This would bring regulation in line with clinical practice and achieve better protection.”

    Avoiding regrettable substitution

    Bisphenol A has been recognised as a substance of very high concern (SVHC) due to its endocrine disrupting properties, since 2017. Therefore, many products marketed for babies are labelled “free from bisphenol A”. However, this has led to regrettable substitution to other bisphenol groups that were not yet recognised as EDCs but may share some of the same properties. Anne-Simone Parent, ESE expert and professor of Paediatric Endocrinology at the University of Liège in Belgium highlighted in her keynote speech the dangers of Bisphenol to our youngest. "I am pleased that the Commission announced that bisphenols will now be evaluated as a group rather than individually. This enables the process of determining which substances require regulatory action or additional data, and which chemicals do not require further action. Our common purpose should be to safeguard the most vulnerable people, particularly children," Professor Parent stated. The remainder of the year will be critical for chemical regulation due to the continued implementation of the Chemical Strategy for Sustainability, including reviews of significant policy files, such as REACH, CLP and the Cosmetics Products Regulation. With their active participation to the EDC Forum, ESE has highlighted the urgent necessity to further phase out endocrine disrupting chemicals that threaten human health.


    Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

    Thu, 22 Sep 2022 07:15:00 -0500 en text/html https://www.eurekalert.org/news-releases/965413
    Killexams : Top Specialized Hospitals - Endocrinology 1 Mayo Clinic - Rochester Division of Endocrinology, Diabetes, Metabolism, & Nutrition Rochester, MN United States 2 Massachusetts General Hospital Endocrinology Division Boston, MA United States 3 Asan Medical Center Department of Endocrinology and Metabolism Seoul South Korea 4 Cleveland Clinic Endocrinology & Metabolism Institute Cleveland, OH United States 5 The Johns Hopkins Hospital Johns Hopkins Comprehensive Diabetes Center Baltimore, MD United States 6 New York-Presbyterian Hospital-Columbia and Cornell Naomi Berrie Diabetes Center New York, NY United States 7 Mayo Clinic - Phoenix Endocrinology Department Phoenix, AZ United States 8 AP-HP - Hôpital Universitaire Pitié Salpêtrière Service de Diabétologie Paris France 9 Seoul National University Hospital Department of Endocrinology and Metabolism Seoul South Korea 10 The Catholic University Of Korea - Seoul St. Mary’s Hospital Department of Endocrinology & Metabolism Seoul South Korea 11 Brigham And Women's Hospital Division of Endocrinology, Diabetes and Hypertension Boston, MA United States 12 Severance Hospital - Yonsei University Division of Endocrinology and Metabolism Seoul South Korea 13 Beth Israel Deaconess Medical Center Division of Endocrinology, Diabetes and Metabolism Boston, MA United States 14 Charité - Universitätsmedizin Berlin Medizinische Klinik für Endokrinologie und Stoffwechselmedizin Berlin Germany 15 Hospital of the University of Pennsylvania - Penn Presbyterian Endocrinology, Diabetes, and Metabolism Philadelphia, PA United States 16 Ospedale San Raffaele - Gruppo San Donato Medicina Generale Indirizzo Diabetologico ed Endocrino-Metabolico Milan Italy 17 Addenbrooke's Wolfson Diabetes and Endocrine Clinic Cambridge United Kingdom 18 Mount Sinai Hospital Sinai Centre for Diabetes (LSCD) Toronto Canada 19 Samsung Medical Center Department of Endocrinology and Metabolism Medicine Seoul South Korea 20 Hospital Universitari Vall d'Hebron Servicio de Endocrinología y Nutrición Barcelona Spain 21 University of Michigan Hospitals - Michigan Medicine Division of Metabolism, Endocrinology & Diabetes (MEND) Ann Arbor, MI United States 22 UCSF Medical Center UCSF Endocrinology Clinic at Parnassus San Francisco, CA United States 23 The University of Tokyo Hospital Department of Nephrology and Endocrinology Tokyo Japan 24 Mayo Clinic - Jacksonville Division of Endocrinology, Diabetes, Metabolism, & Nutrition Jacksonville, FL United States 25 Northwestern Memorial Hospital Division of Endocrinology, Metabolism and Molecular Medicine Chicago, IL United States 26 AP-HP - Hôpital Cochin Service d'Endocrinologie Paris France 27 Karolinska Universitetssjukhuset Endokrinmottagningen i Huddinge Solna Sweden 28 The Mount Sinai Hospital Endocrinology Department New York, NY United States 29 Queen Elizabeth Hospital Birmingham Diabetes Centre Birmingham United Kingdom 30 Cedars-Sinai Medical Center Diabetes Outpatient Treatment & Education Center Los Angeles, CA United States 31 UCLA Health – Ronald Reagan Medical Center Gonda Diabetes Center Los Angeles, CA United States x 32 KyungHee University Medical Center Department of Endocrinology and Metabolism Seoul South Korea 33 Hospital Universitario La Paz Servicio de Endocrinología Madrid Spain 34 Toronto General - University Health Network Endocrinology Clinics Toronto Canada 35 Herz- und Diabeteszentrum NRW Endokrinologie Bad Oeynhausen Germany 36 AP-HP - Hôpital Bichat-Claude-Bernard Service de Biochimie métabolique et nutrition Paris France 37 University of Washington Medical Center Endocrine Care Center Seattle, WA United States 38 St. Bartholomew's Hospital Endocrinology London United Kingdom 39 University of Chicago Medical Center Endocrinology & Metabolic Disorders Chicago, IL United States 40 Royal Melbourne Hospital - Parkville Diabetes, gland & hormone diseases Melbourne Australia 41 Hospital General Universitario Gregorio Marañón Servicio de Endocrinología y Nutrición Madrid Spain 42 NYU Langone Hospitals Division of Endocrinology, Diabetes and Metabolism New York, NY United States 43 Vancouver General Hospital Gordon and Leslie Diamond Health Care Centre Vancouver Canada 44 Guy's Hospital Diabetes and endocrinology service London United Kingdom 45 Duke University Hospital Division of Endocrinology, Metabolism, and Nutrition Durham, NC United States 46 Universitätsklinikum Tübingen Innere Medizin IV - Diabetologie, Endokrinologie, Nephrologie Tübingen Germany 47 Hôpital Lyon Sud (HCL) Service d'Endocrinologie-Diabète-Nutrition Pierre Benite France 48 Presidio Ospedaliero Molinette - A.O.U. Città della Salute e della Scienza Endocrinologia, Diabetologia e Metabolismo Turin Italy 49 Kyoto University Hospital Department of Diabetes, Endocrinology and Nutrition Kyoto Japan 50 King's College Hospital Endocrinology London United Kingdom 51 Chonbuk National University Hospital Endocrinology and Metabolic Medicine Jeonju South Korea 52 Stanford Health Care - Stanford Hospital Endocrinology Clinic at Boswell Building Stanford, CA United States 53 Policlinico Universitario A. Gemelli Medicina Interna, Endocrinologia e Diabetologia Rome Italy 54 Gangnam Severance Hospital - Yonsei University Department of Endocrinology Seoul South Korea 55 Azienda Ospedaliero Universitaria Pisana UO Endocrinologia 1 Pisa Italy 56 Barnes-Jewish Hospital Washington University Diabetes Center Saint Louis, MO United States 57 Osaka University Hospital Diabetes Center Osaka Japan 58 Oxford University Hospitals Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) Oxford United Kingdom 59 Hospital Clínic de Barcelona Clínico de Enfermedades Digestivas y Metabólicas Barcelona Spain 60 UT Southwestern Medical Center Endocrinology Division Dallas, TX United States 61 UPMC Presbyterian & Shadyside Endocrinology Services Pittsburgh, PA United States 62 Diabetes Klinik Bad Mergentheim Bad Mergentheim Germany 63 UCLA Health – Santa Monica Medical Center Gonda Diabetes Center Santa Monica, CA United States 64 Emory University Hospital Endocrinology services at Emory Clinic 'A' Atlanta, GA United States 65 Nagoya University Hospital Endocrinology and Diabetes Nagoya Japan 66 Hanyang University Medical Center Endocrinology&Metabolism Seoul South Korea 67 Houston Methodist Hospital Endocrinology, Diabetes & Metabolism Houston, TX United States 68 University of California - Davis Medical Center Division of Endocrinology, Diabetes & Metabolism Sacramento, CA United States 69 Hospital Sirio Libanes Centro de Diabetes do Sírio-Libanês Sao Paulo Brazil 70 University of Wisconsin Hospitals Endocrinology, diabetes and metabolism care Madison, WI United States 71 Hospital Israelita Albert Einstein Endocrinologia Pediátrica Sao Paulo Brazil 72 Ohio State University - Wexner Medical Center Division of Endocrinology, Diabetes and Metabolism Columbus, OH United States 73 National University Hospital Division of Endocrinology Singapore Singapore 74 Policlinico Sant'Orsola-Malpighi Ambulatori di Endocrinologia Bologna Italy 75 Ospedale Pediatrico Bambino Gesù di Roma Endocrinologia Rome Italy 76 Rush University Medical Center Endocrinology Services Chicago, IL United States 77 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Endokrinologie und Stoffwechselerkrankungen Mainz Germany 78 Hôpital Saint-Antoine Endocrinologie, diabétologie et endocrinologie de la reproduction Paris France 79 Brigham And Women's Faulkner Hospital Brigham and Women’s Sleep Medicine and Endocrinology Center Boston, MA United States 80 Universitätsklinikum Düsseldorf Klinik für Endokrinologie und Diabetologie Düsseldorf Germany 81 McGill University Health Centre Division of Endocrinology and Metabolism Montreal Canada 82 Abbott Northwestern Hospital Endocrinology Minneapolis, MN United States 83 Johns Hopkins Bayview Medical Center Endocrinology, Diabetes and Metabolism Services Baltimore, MD United States 84 Hospital Ramón y Cajal Servicio de Endocrinología y Nutrición Madrid Spain 85 Ajou University Hospital Endocrinology & Metabolism Suwon South Korea 86 Cleveland Clinic - Florida Department of Endocrinology & Metabolism Weston United States 87 Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Diabetologie und Endokrinologie Bochum Germany 88 Advocate Illinois Masonic Medical Center Diabetes endocrinology Chicago United States 89 MD Anderson Cancer Center Endocrine Center Houston, TX United States 90 Azienda Ospedaliera Universitaria Federico II di Napoli Gastroenterologia, Endocrinologia e Chirugia Endoscopia Napoli Italy 91 The Hospital for Sick Children Endocrinology Toronto Canada 92 University of North Carolina Hospitals UNC Endocrinology at Eastowne Chapel Hill, NC United States 93 Universitätsklinikum Carl Gustav Carus Dresden Bereich Endokrinologie/ Diabetes/ Knochenstoffwechselerkrankungen Dresden Germany 94 Hospital Clínico San Carlos Endocrinología Madrid Spain 95 Steno Diabetes Center Copenhagen Gentofte Denmark 96 University of Miami Hospital Endocrinology, Diabetes and Metabolism Miami, FL United States 97 Yale New Haven Hospital Diabetes Center New Haven, CT United States 98 Chung-Ang University Hospital Division of Endocrinology Seoul South Korea 99 The Catholic University Of Korea - Yeouido St. Mary’s Hospital Endocrinology & Metabolism Seoul South Korea 100 Pusan National University Hospital Endocrinology and Metabolism Busan South Korea 101 AP-HP - Hôpital Bicêtre Endocrinologie – Diabétologie Le Kremlin Bicetre France 102 Hospital das Clinicas da Unicamp de Campinas Endocrinologia-metabologia Campinas Brazil 103 Azienda Ospedaliera San Camillo Forlanini Endocrinologia Rome Italy 104 Chungnam National University Hospital Endocrinology and Metabolism Daejeon South Korea 105 Royal Devon and Exeter Hospital (Wonford) Diabetes, Endocrine (hormones) and Obesity Exeter United Kingdom 106 Foothills Medical Centre Diabetes in Pregnancy Clinic Calgary Canada 107 Ospedale Policlinico San Matteo Medicina Generale IV - Endocrinologia Pavia Italy 108 Kyungpook National University Hospital Endocrinology Center Daegu Metropolitan City South Korea 109 Hospital Universitario Virgen del Rocío Endocrinología y Nutrición Sevilla Spain 110 Chonnam National University Hospital Endocrinology and Metabolism Gwangju South Korea 111 Krankenhaus Sachsenhausen Diabetologie & Endokrinologie Frankfurt am Main Germany 112 LMU Klinikum Medizinische Klinik und Poliklinik IV Munich Germany x 113 Gyeongsang National University Hospital Department of Endocrinology Jinju City South Korea 114 AP-HP - Hôpital Lariboisière Diabétologie Paris France 115 Tohoku University Hospital Nephrology, Hypertension, Endocrinology Sendai Japan 116 Complejo Hospitalario Universitario Infanta Leonor Endocrinología Madrid Spain 117 Centre hospitalier universitaire Lille Endocrinologie, diabétologie, maladies métaboliques et nutrition Lille Cedex France 118 Universitätsklinikum Leipzig Klinik und Poliklinik für Endokrinologie, Nephrologie, Rheumatologie Leipzig Germany 119 Indiana University Health Medical Center Endocrinology & Metabolism Indianapolis, IN United States 120 Aarhus Universitetshospital Department of Endocrinology and Internal Medicine Aarhus Denmark 121 Seoul National University - Bundang Hospital Department of Internal Medicine for Endocrinology Seongnam South Korea 122 University College Hospital Endocrinology service/Diabetes service London United Kingdom 123 Kyushu University Hospital Department of Endocrine and Metabolic Diseases / Diabetes Mellitus Fukuoka Japan 124 Clinica Universidad de Navarra Departamento de Endocrinología y Nutrición Pamplona Spain 125 Universitätsklinikum Köln Poliklinik für Endokrinologie, Diabetologie und Präventivmedizin Cologne Germany 126 AGAPLESION Bethanien Krankenhaus Fachabteilung für Diabetologie Frankfurt Germany 127 Kyoto Medical Center Endocrinology and Metabolism Kyoto Japan 128 Universitätsspital Zürich Klinik für Endokrinologie, Diabetologie und Klinische Ernährung Zurich Switzerland 129 Universitätsklinikum Heidelberg Diabetes- und Adipositas-Zentrum Heidelberg Heidelberg Germany 130 Medizinische Hochschule Hannover Klinik für Gastroenterologie, Hepatologie und Endokrinologie Hanover Germany 131 Kangbuk Samsung Hospital Diabetes & Vascular Center Seoul South Korea 132 AP-HP - Hôpital Européen Georges Pompidou Service de Nutrition Paris France 133 Universitätsklinikum Ulm Innere Medizin I Ulm Germany 134 Korea University - Guro Hospital Endocrinology and Metabolism Seoul South Korea 135 Royal Adelaide Hospital Endocrine & Metabolic Service Adelaide Australia 136 Claraspital Endokrinologie mit Ernährungszentrum Basel Switzerland 137 All India Institute of Medical Sciences - Delhi Endocrine and Metabolic service New Delhi India 138 St Thomas' Hospital Clinics - Endocrinology London United Kingdom 139 Universitätsspital Basel Klinik für Endokrinologie, Diabetologie und Metabolismus Basel Switzerland 140 Tan Tock Seng Hospital (TTSH) Endocrine Clinic and Diabetes Clinic Singapore Singapore 141 Singapore General Hospital (SGH) Diabetes & Metabolism Centre (DMC) Singapore Singapore 142 The Christian Medical College Endocrinology Vellore India 143 Tampere University Hospital Internal Medicine Tampere Finland 144 Korea University - Anam Hospital Endocrinology and Metabolism Seoul South Korea 145 Children's Hospital of Philadelphia Division of Endocrinology and Diabetes Philadelphia, PA United States 146 Tottori University Hospital Department of Endocrinology and Metabolism Yonago Japan 147 PGIMER - Postgraduate Institute of Medical Education and Research Department of Endocrinology Chandigarh India 148 Keio University Hospital Department of Endocrinology, Metabolism and Nephrology Tokyo Japan 149 Hôpital de la Conception Endocrinologie, diabète, maladies métaboliques Marseille France 150 National Cancer Center Department of Internal Medicine Goyang South Korea Wed, 14 Sep 2022 03:03:00 -0500 en text/html https://www.newsweek.com/rankings/worlds-best-specialized-hospitals-2023/endocrinology Killexams : Time to Change Our Flawed Approach to Security Awareness

    Our approach to security awareness is flawed. And we must change it.

    As Russian tanks creaked into Ukraine, CEOs and IT managers throughout the United States and much of the free world started sending out emails warning their employees about impending spear-phishing attacks.

    It made sense: Spear-phishing was what Russians had used on Ukrainians many times in the past half of a decade, such as when they shut down the country's electrical grid on one of its coldest winter nights. It was also what the Russians had used against the Democratic National Committee and targets across the US.

    At one end, the email missives from CEOs were refreshing. People were serious about the threat of phishing, which wasn't the case in 2014 when I started warning about its dangers on CNN.

    At the other end, it was sobering. There wasn't much else organizations had figured out to do.

    Sending messages to warn people was what AOL's CEO resorted to back in 1997, when spear-phishing first emerged and got its name. Budding hackers of the time were impersonating AOL administrators and fishing for subscribers' personal information. That was almost three decades ago, many lifetimes in Internet years.

    In the interim, organizations have spent billions on security technologies and countless hours in security training. For context, a decade ago, Bank of America (BoA) was spending $400 million on cybersecurity. It now spends $1 billion per year on it. Yet thousands of its customer accounts in California were hacked last year.

    And BoA isn't alone. This year, Microsoft, Nvidia, Samsung, LG, and T-Mobile — which recently paid out a $350 million settlement to customers because of a breach in 2021 — were hacked. All fell victim to spear-phishing attacks. No question that the employees in these companies are experienced and well-trained in detecting such attacks.

    Flawed Approach

    Clearly, something is fundamentally flawed in our approach, when you consider that after all this, email-based compromises increased by 35% in 2021, and American businesses lost over $2.4 billion due to it.

    A big part of the problem is the current paradigm of user training. It primarily revolves around some form of cyber-safety instruction, usually following a mock phishing email test. The tests are sent periodically, and user failures are tracked — serving as an indicator of user vulnerability and forming the backbone of cyber-risk computations used by insurers and policymakers.

    There is limited scientific support for this form of training. Most point to short-term value, with its effects wearing off within hours, according to a 2013 study. This has been ignored since the very inception of awareness as a solution.

    There is another problem. Security awareness isn't a solution; it's a product with an ecosystem of deep-pocketed vendors pushing for it. There is legislation and federal policy mandating it, some stemming from lobbying by training organizations, making it necessary for every organization to implement it and users to endure it.

    Finally, there is no valid measurement of security awareness. Who needs it? What type? And how much is enough? There are no answers to these questions.

    Instead, the focus is on whether users fail a phishing test without a diagnosis of the why — the reason behind the failures. Because of this, phishing attacks continue, and organizations have no idea why. Which is why our best defense has been to send out email warnings to users.

    Defend With Fundamentals

    The only way to defend against phishing is to start at the fundamentals. Begin with the key question: What makes users vulnerable to phishing?

    The science of security already provides the answers. It has identified specific mind-level or cognitive factors and behavioral habits that cause user vulnerability. Cognitive factors include cyber-risk beliefs — ideas we hold in our minds about online risk, such as how safe it might be to open a PDF document versus a Word document, or how a certain mobile OS might offer better protection for opening emails. Many such beliefs, some flawed and others accurate, govern how much mental attention we pay to details online.

    Many of us also acquire media habits, from opening every incoming message to rituals such as checking emails and feeds the moment we awake. Some of these are conditioned by apps; others by organizational IT policy. They lead to mindless reactions to emails that increase phishing vulnerability.

    There is another, largely ignored, factor: suspicion. It is that unease when encountering something; that sense that something is off. It almost always leads to information seeking and, armed with the right types of knowledge or experience, leads to deception-detection and correction.

    It did for the former head of the FBI. Robert Muller, after entering his banking information in response to an email request, stopped before hitting Send. Something didn't seem right. In the momentary return to reason caused by suspicion, he realized he was being phished, and changed his banking passwords.

    By measuring suspicion along with the cognitive and behavioral factors leading to phishing vulnerability, organizations can diagnose what makes users vulnerable. This information can be quantified and converted into a risk index, with which they can identify those most at risk, the weakest links, and protect them better.

    Doing this will help us defend users based on a diagnosis of what they need, rather than a training approach that's being sold as a solution — a paradigm that we know doesn't work.

    After billions spent, our best approach remains sending out email warnings about incoming attacks. Surely, we can do better. By applying the science of security, we can. And we must — because spear-phishing presents a clear and present danger to the Internet.

    Wed, 28 Sep 2022 10:32:00 -0500 en text/html https://www.darkreading.com/vulnerabilities-threats/time-to-change-our-flawed-approach-to-security-awareness
    Killexams : Updated diabetes guideline released by the American Association of Clinical Endocrinology features the latest state-of-the-science in diabetes care

    JACKSONVILLE, Fla., Sept. 27, 2022 /PRNewswire/ -- The American Association of Clinical Endocrinology (AACE) is proud to announce the release of its updated guideline for the care and management of people with or at risk for diabetes mellitus. The guideline features 170 updated and new evidence-based clinical practice recommendations for diabetes at every stage, including prevention, diagnosis, and treatment.

    (PRNewsfoto/American Association of Clinical Endocrinology (AACE))

    Released in conjunction with the AACE Cardiometabolic Conference, the guideline addresses a variety of new syllabus related to management of diabetes, including COVID-19 vaccination, telehealth, social determinants of health, male and female infertility, secondary diabetes, and nutritional supplements. Additionally, the 2022 guideline includes expanded sections on management of hyperglycemia in the hospital setting and hypoglycemia, quality of life recommendations on sleep hygiene and depression, and updated safety-oriented recommendations on occupational risk and risk of cancer.

    "The updated diabetes guideline—created by clinicians, for clinicians—can be used by the multi-disciplinary care teams that are involved in the care and management of diabetes," said S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, president of AACE and an author of the guideline. "The guideline is framed to support person-centered, team-based clinical decision-making, which importantly puts the patient at the center to Boost care for people with prediabetes and diabetes." The writing team of nearly 30 experts was led by co-chairs Drs. Larry Blonde and Guillermo Umpierrez and section leaders Drs. Reddy and Janet McGill.

    The 2022 guideline update synthesizes thousands of articles to provide health care professionals with the latest evidence-based information on the total care of diabetes. Particularly important updates of this guideline include the following:

    • Complications-centric recommendations for the use of pharmacotherapy for the management of persons with diabetes
      • Based on the latest landmark cardiovascular outcome trials, the guideline covers the use of newer antihyperglycemic therapies with enhanced safety and classes of drugs that reduce the risk of cardiovascular disease, heart failure and/or chronic kidney disease, independent of glycemic control.
      • To Boost glycemia and address the risk or presence of cardiometabolic complications, this guideline also provides recommendations for FDA-approved weight-loss medications and comprehensive guidance on the management of obesity, which is a cornerstone of care of persons with diabetes.
    • Recommendations for management of comorbidities and complications, including obesity, hypertension, dyslipidemia, retinopathy, neuropathy, diabetic/chronic kidney disease and cardiovascular disease.

    "The guideline takes a fresh look at the latest evidence in today's environment and provides robust guidance for clinicians to ensure we are providing the highest standards of care," said Susan L. Samson, MD, PhD, FRCPC, FACE, interim president elect and treasurer of AACE and an author of the guideline. "AACE has led the way with clinical knowledge of endocrinology since 1991, and I am proud that with this updated guideline, we can continue to be a proactive force in providing diabetes education, support, and guidance."

    To view the full diabetes guideline, visit https://pro.aace.com/disease-state-resources/diabetes/clinical-practice-guidelines/2022-aace-clinical-practice-guideline.

    To learn more about AACE, visit www.aace.com

    ABOUT AACE

    Established in 1991, the American Association of Clinical Endocrinology (AACE) is a global, inclusive community of thousands of endocrine-focused clinical members, affiliates and partners who impact tens of millions of people living with endocrine disorders each year. As the vital hub of knowledge in clinical endocrinology, we use the latest clinical advances to define the best paths of patient care and disease prevention, educate multidisciplinary endocrine care teams and patients, and facilitate collaboration. Together, we are elevating the practice of clinical endocrinology to Boost global health. Visit our website at www.aace.com.

     

    Cision View original content to get multimedia:https://www.prnewswire.com/news-releases/updated-diabetes-guideline-released-by-the-american-association-of-clinical-endocrinology-features-the-latest-state-of-the-science-in-diabetes-care-301633516.html

    SOURCE American Association of Clinical Endocrinology (AACE)

    Tue, 27 Sep 2022 01:10:00 -0500 en text/html https://markets.businessinsider.com/news/stocks/updated-diabetes-guideline-released-by-the-american-association-of-clinical-endocrinology-features-the-latest-state-of-the-science-in-diabetes-care-1031767088
    Killexams : Endocrinologist News and Research

    Using neuroimaging to investigate how petting dogs could help clinicians Boost animal-assisted therapy

    In this interview, News Medical speaks to Rahel Marti, Ph.D. student in the faculty of Psychology at the University of Basel, about her new research, which shows that petting dogs engages the social brain, leading the way for new potentialities in animal-assisted clinical therapy.

    Tue, 27 Sep 2022 12:00:00 -0500 en text/html https://www.news-medical.net/?tag=/Endocrinologist
    Killexams : How to watch as Jupiter and its moons make their closest approach to Earth in 59 years — providing an "extraordinary" view

    Jupiter will look bigger and brighter than normal on Monday night as it rises opposite of the sun and reaches its closest point to Earth in decades. It will be so close that the planet's banding and several of its moons should be visible, NASA said. 

    The gas giant will become visible when it reaches opposition, meaning it rises in the east as the sun sets in the west, a move that happens every 13 months. Tonight will also mark the closest that Jupiter has been to Earth since 1963 – which, according to NASA, is a unique happening that will make it an extra special viewing. 

    At its closest point, the planet will be about 367 million miles from Earth, about 200 million miles closer than when it's at its farthest point. 

    "Jupiter's closest approach to Earth rarely coincides with opposition," NASA said, "which means this year's views will be extraordinary." 

    Those spectacular views are expected to be vivid and detailed, scientists said. 

    "With good binoculars, the banding (at least the central band) and three or four of the Galilean satellites (moons) should be visible," NASA research astrophysicist Adam Kobelski said. 

    There are 53 named moons belonging to the planet, though scientists believe that 79 have been detected. The four largest of the moons are known as the Galilean satellites, named after Galileo Galilei, who first observed them. 

    "It's important to remember that Galileo observed these moons with 17th century optics," Kobelski  said. "One of the key needs will be a stable mount for whatever system you use." 

    The best spots to see Jupiter will be from high elevations where it is dark and dry, Kobelski said, and it should visible for the next few days. 

    "Take advantage of good weather on either side of this date to take in the sight," he said. "Outside of the moon, it should be one of the (if not the) brightest objects in the night sky." 

    Mon, 26 Sep 2022 03:04:00 -0500 en-US text/html https://www.cbsnews.com/news/how-to-watch-jupiter-closest-approach-earth-since-1963/
    Killexams : Scientists say a One Health approach to plant health is vital to achieving sustainable global food security

    A team of scientists argues that a One Health approach to plant health is vital if we are to sustainably feed a growing population expected to reach 10 billion by 2050.

    The researchers, who published a commentary in the CABI Agriculture and Bioscience journal, suggest that a One Health perspective can help optimize net benefits from to realize greater food security and nutrition gains.

    One Health is an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals and ecosystems. It recognizes that the health of humans, domestic and wild animals, plants and the wider environment are closely linked and interdependent.

    Dr. Vivian Hoffmann, Senior Research Fellow at the International Food Policy Research Institute (IFPRI), is a lead author of the commentary, which focuses on two primary trade-offs that lie at the interface of plant health with animal, ecosystem and human health.

    Dr. Hoffmann and the researchers say that protecting plant health through use of agrochemicals versus minimizing risks to human health and antimicrobial and insecticide resistance is one consideration. Another, the scientists argue, is ensuring food security by prioritizing the health of crops to maximize versus protecting environmental systems.

    The commentary, which stems from a webinar organized by CGIAR and attended by over 200 participants from around the world, discusses challenges and opportunities for advancement associated with each of these trade-offs—by taking account of how the priorities and constraints of stakeholders may vary by gender.

    It stresses that building the capacity of regulatory bodies in low- and middle-income countries to conduct cost-benefit analysis has the potential to Boost decision-making in the context of these and other multi-dimensional trade-offs.

    The webinar included presentations on the sustainable intensification, benefits to plant health, and risks to human health, of using manure and wastewater to fertilize ; Tanzania's experience with "pesticide regulation" management of plant-associated food safety hazards where regulatory capacity is weak, and the role of gender in One Health.

    Dr. Hoffmann said, "Increasing crop yields through healthy plants is critical to achieving food security for a growing global population. But agricultural production also poses threats to environmental processes that underpin human health."

    The commentary, for instance, highlights that agriculture contributes 34% of , consumes 84% of fresh water and is the single biggest source of eutrophication causing nitrogen and phosphorus pollution in aquatic systems.

    "Interventions to encourage plant health practices that balance ecological concerns and food production will need to consider the constraints, needs, and motivations of farmers, including those mediated by gender," Dr. Hoffmann added.

    Webinar participants made the point that farmers and other stakeholders of limited means, and women in particular, may not have the luxury of prioritizing .

    Dr. Hoffmann said, "This points to the need for external financing, perhaps through international green development or climate funds, to promote ecologically sustainable agricultural practices."

    The scientists also believe that trade-offs are expected to depend critically on the intensity of exposure to environmental hazards, status, and income levels—all of which vary across countries. There is therefore a need, they say, for context-specific analysis, and as such, greater capacity for in low land middle-income countries as a matter of priority.



    More information: A one health approach to plant health, CABI Agriculture and Bioscience (2022). DOI: 10.1186/s43170-022-00118-2

    Provided by CABI

    Citation: Scientists say a One Health approach to plant health is vital to achieving sustainable global food security (2022, September 28) retrieved 17 October 2022 from https://phys.org/news/2022-09-scientists-health-approach-vital-sustainable.html

    This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

    Wed, 28 Sep 2022 11:04:00 -0500 en text/html https://phys.org/news/2022-09-scientists-health-approach-vital-sustainable.html
    Killexams : Kinlaw's day-by-day approach is paying dividends for 49ers

    49ers

    Kinlaw's day-by-day approach is paying dividends for 49ers

    SANTA CLARA -- Javon Kinlaw’s steady, methodical approach to the game already has started to pay off on the field, but the 49ers defensive lineman shared it is still the beginning of his journey

    Kinlaw always wants to be a factor on the field, but his first two NFL seasons did not go as planned. After a second knee procedure that ended his 2021 campaign, the South Carolina product is finally pain-free and the results of his hard work are evident in games. 

    Kinlaw shared with NBC Sports Bay Area that he is nowhere close to being a finished product.

    “You just got to have patience, it’s not a sprint,” Kinlaw said this week. “You got to be in this thing for the long run. When you look at it like that, it helps you slow down and not really worry about the future. You just have to focus on one day at a time.”

    When speaking to Kinlaw, you almost expect his voice to match his hulking physical appearance. But he is soft spoken, and his words are as well thought out as his play on the field. It is very clear that he has substantial goals in mind for his NFL career. 

    Defensive coordinator DeMeco Ryans has taken notice of how Kinlaw’s improved technique has had an effect on opposing quarterbacks. The lineman’s 6-foot-5 frame and lengthy reach has caused errant throws and misfires by opponents already. 

    Ryans is excited by the thought of Kinlaw’s full potential. 

    “What I see from Kinlaw is growth,” Ryans said on Thursday. “It’s steady growth, each and every week. He’s getting better and better. So, who knows what it’ll be mid-season, end of the season, how good he’ll be playing, but I think it’s going to be really great for us.”

    Kinlaw’s life has been filled with adversity, which is what he credits for his mental approach to the game. The 24-year-old has been keeping his head down, making each day count, fueled by the same motivation he has had since he was a child.

    Not looking too far ahead has kept Kinlaw grounded and focused, which has influenced his improvement on the field. The imposing lineman sets small goals for each day and each practice because that will benefit him in the long run. 

    “The little things always take care of the big things especially with me, that’s just who I am,” Kinlaw said. “I pay attention to the small details because small details are what take your game to the next level.”

    RELATED: How Ryans believes O-line can subdue old friend D.J. Jones 

    Kinlaw’s three pressures through the club’s first two games don’t necessarily reflect his impact on the game. Increased double teams are how opponents have been able to neutralize the lineman’s ability to get into the backfield, but that has helped free up his fellow linemen in games. 

    “I’m happy where Kinlaw is going,” Ryans said. “It’s exciting because I see him continuing to get better. That’s the cool part about him.”  

    Download and follow the 49ers Talk Podcast

    Sat, 24 Sep 2022 06:52:00 -0500 en text/html https://www.nbcsports.com/bayarea/49ers/javon-kinlaws-day-day-approach-going-be-really-great-49ers
    SEND exam dump and training guide direct download
    Training Exams List